Clinical trial
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of…
NCT00209612 · Hokkaido Gastrointestinal Cancer Study Group, Other · Withdrawn
Key facts
| NCT number | NCT00209612 |
|---|---|
| Title | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. |
| Official title | Phase I/II Study of Biweekly Administration Regimen of Paclitaxel Combined With CPT-11 in Patients With Second Line Chemotherapy of Inoperable or Recurrent Gastric Cancer(GC). |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Collaborators | Hokkaido University Hospital |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | Taxol, Campt, Topotesin |
| Enrollment | 40 |
| Start date | Apr 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 17, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: